Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Sniatynski

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Patterns (New York, N.Y.)|February 24, 2022
Ranks underlie outcome of combining classifiers: Quantitative roles for <i>diversity</i> and <i>accuracy</i>Matthew J Sniatynski, John A Shepherd, Thomas Ernst, et al.
Journal of the American Society for Mass Spectrometry|January 31, 2006
Multiple neutral loss monitoring (MNM): a multiplexed method for post-translational modification screeningMichael D Hoffman, Matthew J Sniatynski, Jason C Rogalski, et al.
Journal of the American Society for Mass Spectrometry|March 29, 2005
Statistical evaluation of electrospray tandem mass spectra for optimized peptide fragmentationJason C Rogalski, Michael S Lin, Matthew J Sniatynski, et al.
Journal of Lipid Research|May 22, 2013
Dietary macronutrients modulate the fatty acyl composition of rat liver mitochondrial cardiolipinsIrina G Stavrovskaya, Susan S Bird, Vasant R Marur, et al.
Analytical Chemistry|September 29, 2018
Optimization of Electrospray Ionization Source Parameters for Lipidomics To Reduce Misannotation of In-Source Fragments as Precursor IonsRose M Gathungu, Pablo Larrea, Matthew J Sniatynski, et al.
Journal of Affective Disorders|January 16, 2025
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorderSudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive DisorderSudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 14, 2023
Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex-Dependent MannerTianlu Chen, Lu Wang, Guoxiang Xie, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Patterns (New York, N.Y.)|February 24, 2022
Ranks underlie outcome of combining classifiers: Quantitative roles for <i>diversity</i> and <i>accuracy</i>Matthew J Sniatynski, John A Shepherd, Thomas Ernst, et al.
Journal of the American Society for Mass Spectrometry|January 31, 2006
Multiple neutral loss monitoring (MNM): a multiplexed method for post-translational modification screeningMichael D Hoffman, Matthew J Sniatynski, Jason C Rogalski, et al.
Journal of the American Society for Mass Spectrometry|March 29, 2005
Statistical evaluation of electrospray tandem mass spectra for optimized peptide fragmentationJason C Rogalski, Michael S Lin, Matthew J Sniatynski, et al.
Journal of Lipid Research|May 22, 2013
Dietary macronutrients modulate the fatty acyl composition of rat liver mitochondrial cardiolipinsIrina G Stavrovskaya, Susan S Bird, Vasant R Marur, et al.
Analytical Chemistry|September 29, 2018
Optimization of Electrospray Ionization Source Parameters for Lipidomics To Reduce Misannotation of In-Source Fragments as Precursor IonsRose M Gathungu, Pablo Larrea, Matthew J Sniatynski, et al.
Journal of Affective Disorders|January 16, 2025
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorderSudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive DisorderSudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 14, 2023
Serum Bile Acids Improve Prediction of Alzheimer's Progression in a Sex-Dependent MannerTianlu Chen, Lu Wang, Guoxiang Xie, et al.
Pageof 2